Artelo Biosciences (ARTL) Assets (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Assets of $2.8 million for Q4 2025, down 40.38% year-over-year from $4.7 million in Q4 2024, and down 34.36% quarter-over-quarter from $4.3 million in Q3 2025.
Artelo Biosciences (ARTL) Assets (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Assets for 12 consecutive years, with $2.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets fell 40.38% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (down 40.38% YoY), while the FY2025 annual figure was $2.8 million, down 40.38% from the prior year.
- Assets fell to $2.8 million in Q4 2025 per ARTL's latest filing, from $4.3 million in the prior quarter.
- Across five years, Assets topped out at $29.0 million in Q4 2021 and bottomed at $2.8 million in Q4 2025.
- Historically, Assets has averaged $13.5 million across 5 years, with a median of $12.8 million in 2021.
- Annual changes were most pronounced in 2021 — Assets surged 253.22% — and 2025, when it sank 66.05%.
- Artelo Biosciences' Assets stood at $29.0 million in 2021, then fell by 29.58% to $20.4 million in 2022, then tumbled by 36.14% to $13.0 million in 2023, then plunged by 63.98% to $4.7 million in 2024, then plunged by 40.38% to $2.8 million in 2025.
- Business Quant data shows ARTL's Assets at $2.8 million in Q4 2025, $4.3 million in Q3 2025, and $4.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 19.82 Bn |
| 10 | Artelo Biosciences | 113,239.32 | -486,760.68 | - | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 4.36 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.70 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 8.33 Mn |
| Mar 31, 2024 | 10.35 Mn |
| Dec 31, 2023 | 13.04 Mn |
| Sep 30, 2023 | 15.50 Mn |
| Jun 30, 2023 | 16.88 Mn |
| Mar 31, 2023 | 18.48 Mn |
| Dec 31, 2022 | 20.42 Mn |
| Sep 30, 2022 | 22.42 Mn |
| Jun 30, 2022 | 24.41 Mn |
| Mar 31, 2022 | 26.70 Mn |
| Nov 30, 2021 | 29.00 Mn |
| Aug 31, 2021 | 12.64 Mn |
| May 31, 2021 | 12.34 Mn |
| Feb 28, 2021 | 13.44 Mn |